Spruce Biosciences Files 2024 10-K
Ticker: SPRB · Form: 10-K · Filed: Apr 15, 2025 · CIK: 1683553
| Field | Detail |
|---|---|
| Company | Spruce Biosciences, Inc. (SPRB) |
| Form Type | 10-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals, financials
Related Tickers: SPRB
TL;DR
SPRB 2024 10-K filed. Financials, stock, warrants, term loan details out.
AI Summary
Spruce Biosciences, Inc. filed its 2024 10-K on April 15, 2025, reporting on its fiscal year ending December 31, 2024. The company, located at 611 Gateway Boulevard, Suite 740, South San Francisco, CA, operates in the Pharmaceutical Preparations sector. Key financial elements include common stock, warrants, and a term loan, with specific dates like November 1, 2020, and December 31, 2024, appearing in financial context.
Why It Matters
This filing provides investors with a comprehensive overview of Spruce Biosciences' financial health, operational performance, and risk factors for the fiscal year 2024, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Spruce Biosciences faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K filing.)
- 2025-04-15 — Filing Date (Date the 10-K was officially submitted to the SEC.)
- 1231 — Fiscal Year End (Indicates the end of the fiscal year for reporting purposes.)
Key Players & Entities
- SPRUCE BIOSCIENCES, INC. (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 2025-04-15 (date) — Filing Date
- 611 GATEWAY BOULEVARD, SUITE 740 (address) — Business Address
- SOUTH SAN FRANCISCO, CA (location) — Business Address City and State
- 2834 (industry_code) — Standard Industrial Classification (Pharmaceutical Preparations)
- 001-39594 (sec_file_number) — SEC File Number
- SiliconValleyBankMember (company) — Financial Institution Mentioned
- CommonStockMember (financial_instrument) — Financial Instrument
- TermLoanMember (financial_instrument) — Financial Instrument
FAQ
What is Spruce Biosciences, Inc.'s primary business activity?
Spruce Biosciences, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code 2834.
When did Spruce Biosciences, Inc. file its 2024 10-K report?
The 10-K report for the fiscal year ending December 31, 2024, was filed on April 15, 2025.
What is the company's principal executive office address?
The company's business address is 611 Gateway Boulevard, Suite 740, South San Francisco, CA 94080.
What types of financial instruments are mentioned in relation to Spruce Biosciences, Inc.?
The filing mentions common stock, warrants, and a term loan, including specific references to Silicon Valley Bank and a Second Tranche Term Loan.
What is the SEC file number for Spruce Biosciences, Inc.?
The SEC file number for Spruce Biosciences, Inc. is 001-39594.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 15, 2025 regarding SPRUCE BIOSCIENCES, INC. (SPRB).